blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4152004

EP4152004 - ASSAY FOR JC VIRUS ANTIBODIES [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  18.10.2024
Database last updated on 24.01.2025
FormerGrant of patent is intended
Status updated on  26.06.2024
FormerExamination is in progress
Status updated on  01.12.2023
FormerRequest for examination was made
Status updated on  29.09.2023
FormerThe application has been published
Status updated on  17.02.2023
Most recent event   Tooltip22.11.2024Change - divisional application(s)published on 25.12.2024  [2024/52]
Applicant(s)For all designated states
Biogen MA Inc.
225 Binney Street
Cambridge, MA 02142 / US
[2023/12]
Inventor(s)01 / GORELIK, Leonid
Quincy, 02171 / US
02 / SIMON, Kenneth, J.
Cambridge, 02141 / US
03 / SUBRAMANYAM, Meena
Stoneham, 02180 / US
04 / RUSHE, Mia, Marie
Everett, 02149 / US
 [2023/12]
Representative(s)Pohlman, Sandra M.
df-mp Dörries Frank-Molnia & Pohlman
Patentanwälte Rechtsanwälte PartG mbB
Theatinerstrasse 16
80333 München / DE
[2023/12]
Application number, filing date22191259.511.01.2011
[2023/12]
Priority number, dateUS201029404810P11.01.2010         Original published format: US 29404810 P
US201031619310P22.03.2010         Original published format: US 31619310 P
[2023/12]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP4152004
Date:22.03.2023
Language:EN
[2023/12]
Type: B1 Patent specification 
No.:EP4152004
Date:20.11.2024
Language:EN
[2024/47]
Search report(s)(Supplementary) European search report - dispatched on:EP10.02.2023
ClassificationIPC:G01N33/68
[2023/12]
CPC:
G01N33/6854 (EP); G01N33/56983 (KR,US); G01N2333/025 (EP,US);
G01N2469/20 (EP,US); G01N2800/50 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/44]
Former [2023/12]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
Extension statesBA22.09.2023
ME22.09.2023
TitleGerman:ASSAY FÜR JC-VIREN-ANTIKÖRPER[2023/12]
English:ASSAY FOR JC VIRUS ANTIBODIES[2023/12]
French:ESSAI D'ANTICORPS ANTI-VIRUS JC[2023/12]
Examination procedure22.09.2023Amendment by applicant (claims and/or description)
22.09.2023Examination requested  [2023/44]
22.09.2023Date on which the examining division has become responsible
16.10.2023Observations by third parties
05.12.2023Despatch of a communication from the examining division (Time limit: M04)
04.04.2024Reply to a communication from the examining division
16.05.2024Observations by third parties
27.06.2024Communication of intention to grant the patent
14.10.2024Fee for grant paid
14.10.2024Fee for publishing/printing paid
14.10.2024Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP11732315.4  / EP2524060
EP17203178.3  / EP3339865
Divisional application(s)EP24213770.1
Fees paidRenewal fee
19.08.2022Renewal fee patent year 03
19.08.2022Renewal fee patent year 04
19.08.2022Renewal fee patent year 05
19.08.2022Renewal fee patent year 06
19.08.2022Renewal fee patent year 07
19.08.2022Renewal fee patent year 08
19.08.2022Renewal fee patent year 09
19.08.2022Renewal fee patent year 10
19.08.2022Renewal fee patent year 11
19.08.2022Renewal fee patent year 12
19.01.2023Renewal fee patent year 13
23.01.2024Renewal fee patent year 14
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US6238859  (LUEKE WOLFGANG [DE], et al);
by applicantUS3817837
 US3850752
 US3939350
 US3996345
 US4275149
 US4277437
 US4366241
otherWO2011085369
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.